Form 8-K - Current report:
SEC Accession No. 0000318306-12-000055
Filing Date
2012-10-26
Accepted
2012-10-26 16:12:40
Documents
5
Period of Report
2012-10-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 FORM 8K r8k-507.htm 8-K 30945
2 PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT r8k-508.htm EX-10.1 308989
3 INVESTOR RIGHTS AGREEMENT r8k-509.htm EX-10.2 211390
4 FORM OF WARRANT r8k-510.htm EX-10.3 154561
5 CERTIFICATE OF DESIGNATIONS, RIGHTS AND PREFERENCES OF SERIES B CUMULATIVE CONVE r8k-511.htm EX-10.4 146014
  Complete submission text file 0000318306-12-000055.txt   853390
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1025
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 121164589
SIC: 2834 Pharmaceutical Preparations